Narrow search
Showing 1 - 10 of 55,239
Cover Image
The importance of the first generic substitution : evidence from Sweden
Janssen, Aljoscha; Granlund, David - 2022
We analyze changes in the willingness to substitute from prescribed pharmaceuticals to more affordable generic equivalents in response to the first experience with a substitution. Using Swedish individual-level data of prescribed and dispensed pharmaceuticals, we employ a dynamic event study and...
Persistent link: https://www.econbiz.de/10013175464
Cover Image
Effects of new control systems in Swedish health-care organizations
Charpentier, Claes; Samuelson, Lars A. - 1994
Persistent link: https://www.econbiz.de/10000896385
Cover Image
Cost containment and efficiency in national health systems : a global comparison
Rapoport, John (ed.) - 2009 - 1. Aufl.
Written by health policy experts, the book gives a comprehensive overview of 8 different national health care systems and focuses in particular on the different approaches to maintain efficiency and to contain overall healthcare costs.
Persistent link: https://www.econbiz.de/10003712336
Cover Image
Bör p-piller subventioneras? : konsekvenser för barnafödande, utbildning och arbetsmarknad
Grönqvist, Hans - In: Ekonomisk debatt 37 (2009) 6, pp. 18-26
Persistent link: https://www.econbiz.de/10003893615
Cover Image
Economic policy in health care : sickness absence and pharmaceutical costs
Granlund, David (contributor) - 2007
Persistent link: https://www.econbiz.de/10003456103
Cover Image
Introducing activity-based financing : a review of experience in Australia, Denmark, Norway and Sweden
Street, Andrew; Vitikainen, Kirsi; Bjorvatn, Afsaneh; … - 2007
Persistent link: https://www.econbiz.de/10003563294
Cover Image
The future of retirement in Sweden
Sundén, Annika E. - In: Reinventing the retirement paradigm, (pp. 240-259). 2005
Persistent link: https://www.econbiz.de/10003300101
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - 2012
expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low. -- longevity … ; pharmaceutical ; innovation ; drugs ; Sweden …
Persistent link: https://www.econbiz.de/10009571756
Cover Image
Effects of pharmaceutical price regulation : China's evidence between 1997 and 2008
Wu, Binzhen; Zhang, Qiong; Qiao, Xue - In: Journal of the Asia Pacific economy 20 (2015) 2, pp. 290-329
Persistent link: https://www.econbiz.de/10011378658